Skip to the page

Data / Form D filings / GABA Therapeutics, Inc.

GABA Therapeutics, Inc.: Form D filings

GABA Therapeutics, Inc., a pharmaceuticals company in Newport Beach, CA, filed 2 Form D notices with the SEC between 2019 and 2023. The latest, on October 10, 2023, reports $500,000 sold of a $1 million offering to 3 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5000 BIRCH STREET, WEST TOWER,, SUITE 3000, Newport Beach, CA, 92660
Phone
(949) 231-2244
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1789541

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 10, 2023New notice$1,000,000$500,000$500,0003Sep 26, 2023sec.gov
Oct 18, 2019New noticeIndefinite$21,500,0002Aug 29, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ryan Christian BarrettDirector
H. Christian FibigerDirector
Srinivas Christian RaoDirector
Mario SaltarelliExecutive Officer, Director
Richard FarrellExecutive Officer, Director

Other pharmaceuticals companies in California that filed recently

Every Form D from the week of Oct 9, 2023 · All recent filings in California · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what GABA Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.